Schedule 13G ownership disclosure

Aldeyra Therapeutics Inc

Security class unavailable · CUSIP: 01438T106

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,877,091
Percent of class
6.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000904454-20-000020
Form type
SC 13G/A
Filer
Aldeyra Therapeutics, Inc.
CIK
CIK 1341235
Filed
Jan 10, 2020
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SC 13G/A | SEC Filings Hub